Utilization patterns of extracorporeal membrane oxygenation in neonates in the United States 1997-2012

J Pediatr Surg. 2017 Oct;52(10):1681-1687. doi: 10.1016/j.jpedsurg.2017.05.026. Epub 2017 Jun 1.

Abstract

Background: Extracorporeal membrane oxygenation (ECMO) remains one of the most intensive therapies for newborns in the United States. However, there is limited information on resource utilization for neonates receiving ECMO.

Methods: We conducted a retrospective data analysis of the Kids' Inpatient Database from 1997 to 2012. Bivariate and multivariate analysis was completed to identify predictors of LOS, hospital costs and mortality. Cardiac and non-cardiac diagnoses of neonates receiving ECMO were also included in the bivariate and multivariable analysis.

Results: Of the 5151 ECMO cases, survival to discharge was 62%. 22% had a principal cardiac diagnosis. After adjusting for covariates, increased mortality was associated with treatment in the midwest compared to the northeast region (aOR=2.0, p<0.01) and decreased among neonates with a non-cardiac diagnosis (aOR=0.4, p<0.01). Living in midwest was associated with longer LOS by 13days and increased hospital costs by 63,000 dollars (p<0.01). When stratified by non-cardiac diagnoses, infants with a diagnosis of congenital diaphragmatic hernia was associated with increased mortality (2.3, p<0.01) and longer LOS (25, p<0.01) and increased costs (11,100, p<0.01).

Conclusion: Neonates who received ECMO in certain regions of the United States were associated with poorer survival outcomes as well as increased LOS and hospital costs.

Type of study: Retrospective study.

Level of evidence: Level III.

Keywords: Charges; Costs; ECMO; Length of stay; Neonates; Outcomes; Utilization patterns.

MeSH terms

  • Extracorporeal Membrane Oxygenation / economics*
  • Extracorporeal Membrane Oxygenation / mortality
  • Extracorporeal Membrane Oxygenation / statistics & numerical data*
  • Female
  • Hernias, Diaphragmatic, Congenital / mortality
  • Hernias, Diaphragmatic, Congenital / therapy*
  • Hospital Costs
  • Humans
  • Infant
  • Infant, Newborn
  • Male
  • Multivariate Analysis
  • Retrospective Studies
  • Treatment Outcome
  • United States